From Casetext: Smarter Legal Research

Novartis Pharm. Corp. v. Torrent Pharma

United States Court of Appeals, Federal Circuit
Sep 3, 2024
No. 2023-2219 (Fed. Cir. Sep. 3, 2024)

Opinion

2023-2219

09-03-2024

NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellant v. TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LTD., Defendants-Appellees


This order is nonprecedential.

Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-01979-RGA, Judge Richard G. Andrews.

ORDER

Upon consideration of the parties' joint stipulation of voluntary dismissal of this appeal, pursuant to Federal Rule of Appellate Procedure 42(b)(1), ECF No. 18, IT IS ORDERED THAT:

(1) The appeal is voluntarily dismissed.

(2) Each side shall bear its own costs.


Summaries of

Novartis Pharm. Corp. v. Torrent Pharma

United States Court of Appeals, Federal Circuit
Sep 3, 2024
No. 2023-2219 (Fed. Cir. Sep. 3, 2024)
Case details for

Novartis Pharm. Corp. v. Torrent Pharma

Case Details

Full title:NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellant v. TORRENT…

Court:United States Court of Appeals, Federal Circuit

Date published: Sep 3, 2024

Citations

No. 2023-2219 (Fed. Cir. Sep. 3, 2024)